Details of Metabolite
Full List of Protein(s) Regulating This Metabolite | ||||||
---|---|---|---|---|---|---|
GPCR rhodopsin (GPCR-1) | ||||||
Adrenergic receptor beta-3 (ADRB3) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Agonist (CL-316,243) of Adrb3 | |||||
Induced Change | Malic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that agonist of ADRB3 leads to the increase of malic acid levels compared with control group. | |||||
Hydrolases (EC 3) | ||||||
Leukotriene-C4 hydrolase (GGT1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[2] | ||||
Introduced Variation | Knockdown (siRNA) of GGT1 | |||||
Induced Change | Malic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Renal cell carcinoma [ICD-11: 2C90] | |||||
Details | It is reported that knockdown of GGT1 leads to the increase of malic acid levels compared with control group. | |||||
Mitochondrial carrier (MC) | ||||||
Oxoglutarate/malate carrier protein (SLC25A11) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[3] | ||||
Introduced Variation | Knockdown (shRNA) of SLC25A11 | |||||
Induced Change | Malic acid concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that knockdown of SLC25A11 leads to the decrease of malic acid levels compared with control group. | |||||
Oxidoreductases (EC 1) | ||||||
Alpha-ketoglutarate dehydrogenase (OGDH) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Knockout of OGDH | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
Details | It is reported that knockout of OGDH leads to the decrease of malic acid levels compared with control group. | |||||
D-beta-hydroxybutyrate dehydrogenase (BDH1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[5] | ||||
Introduced Variation | Knockdown (shRNA) of BDH1 | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that knockdown of BDH1 leads to the decrease of malic acid levels compared with control group. | |||||
Formyltetrahydrofolate dehydrogenase (ALDH1L2) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[6] | ||||
Introduced Variation | Mutation of ALDH1L2 | |||||
Induced Change | Malic acid concentration: increase (FC = 2.78) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Genetic disorders of keratinisation [ICD-11: EC20] | |||||
Details | It is reported that mutation (patients) of ALDH1L2 leads to the increase of malic acid levels compared with control group. | |||||
Green heme-binding protein (FLR) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[7] | ||||
Introduced Variation | Knockout of BLVRB | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of BLVRB leads to the decrease of malic acid levels compared with control group. | |||||
L-2-hydroxyglutarate dehydrogenase (L2HGDH) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[8] | ||||
Introduced Variation | Mutation (Nonsense mutations or missense mutations) of L2hgdh | |||||
Induced Change | Malic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Melanoma [ICD-11: 2C30] | |||||
Details | It is reported that mutation (nonsense mutations or missense mutations leading to KMT2D loss) of L2hgdh leads to the increase of malic acid levels compared with control group. | |||||
Pore-forming PNC peptide (PNC) | ||||||
Cellular tumor antigen p53 (TP53) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[9] | ||||
Introduced Variation | Knockout of TP53 | |||||
Induced Change | Malic acid concentration: increase (Log2 FC=1.75) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colon cancer [ICD-11: 2B90] | |||||
Details | It is reported that knockout of TP53 leads to the increase of malic acid levels compared with control group. | |||||
Transcription factor (TF) | ||||||
Forkhead box protein O1 (FOXO1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[10] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Malic acid concentration: increase (FC = 1.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of malic acid levels compared with control group. | |||||
Myc proto-oncogene protein (MYC) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[11] | ||||
Introduced Variation | Knockdown (siRNA) of MYC | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Colorectal cancer [ICD-11: 2B91] | |||||
Details | It is reported that knockdown of MYC leads to the decrease of malic acid levels compared with control group. | |||||
Transferases (EC 2) | ||||||
Deacetylase sirtuin-5 (SIRT5) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[12] | ||||
Introduced Variation | Knockout of Sirt5 | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of Sirt5 leads to the decrease of malic acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[13] | ||||
Introduced Variation | Knockout of Sirt5 | |||||
Induced Change | Malic acid concentration: increase (FC = 1.23) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of Sirt5 leads to the increase of malic acid levels compared with control group. | |||||
Isoprenylcysteine carboxylmethyltransferase (ICMT) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[14] | ||||
Introduced Variation | Inhibition (Cysmethynil) of ICMT | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Breast cancer [ICD-11: 2C60] ... | |||||
Details | It is reported that inhibition of ICMT leads to the decrease of malic acid levels compared with control group. | |||||
Lipoyl synthase (LIAS) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[4] | ||||
Introduced Variation | Knockout of LIAS | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Cervical Cancer [ICD-11: 2C77] | |||||
Details | It is reported that knockout of LIAS leads to the decrease of malic acid levels compared with control group. | |||||
SNF-related serine/threonine-protein kinase (SNRK) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[15] | ||||
Introduced Variation | Knockdown (shRNA) of SNRK | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockdown of SNRK leads to the decrease of malic acid levels compared with control group. | |||||
Succinyl CoA:3-oxoacid CoA transferase (SCOT) | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[5] | ||||
Introduced Variation | Overexpression of OXCT1 | |||||
Induced Change | Malic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that overexpression of OXCT1 leads to the increase of malic acid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[5] | ||||
Introduced Variation | Knockdown (shRNA) of OXCT1 | |||||
Induced Change | Malic acid concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Hepatocellular carcinoma [ICD-11: 2C12] | |||||
Details | It is reported that knockdown of OXCT1 leads to the decrease of malic acid levels compared with control group. | |||||
Transaldolase (TALDO1) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Protein Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[16] | ||||
Introduced Variation | Knockout of Taldo1 | |||||
Induced Change | Malic acid concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of Taldo1 leads to the increase of malic acid levels compared with control group. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.